Dr Pascal RichetteRhumatologue à Paris

2026Arthritis care & researchPubMed

Response to Allopurinol and Febuxostat According to the Fractional Excretion of Urate in Men With Gout

2026JAMA internal medicinePubMed

Urate Lowering and Cardiovascular Risk-Extending the Benefits of a Treat-to-Target Strategy in Gout

2026Diagnostic and interventional imagingPubMed

Photon-counting CT of chronic gout of the hand

2025RadiologyPubMed

Photon-counting CT of Bone Erosions Induced by Gouty Tophi

2025Arthritis & rheumatology (Hoboken, N.J.)PubMed

Short-Term Risk of Cardiovascular Events in People Newly Diagnosed With Gout

2025Joint bone spinePubMed

Addition of allopurinol to traditional Vietnamese medicine shows major improvement of 100 gout patients in a single center one-year prospective study

2025Nature reviews. RheumatologyPubMed

Factors beyond urate levels for managing gout flares

2025Joint bone spinePubMed

Time-course of tophus resolution on Dual-energy CT and ultrasound after 24months of a treat-to-target strategy: Results from GOUT-DECTUS study

2024Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseasesPubMed

Cardiovascular Safety of Febuxostat in Patients With Gout or Hyperuricemia: A Systematic Review of Randomized Controlled Trials

2024Arthritis & rheumatology (Hoboken, N.J.)PubMed

Weight Loss for Patients With Gout and Concomitant Obesity: A Proof-of-Concept Randomized Trial

2024Annals of the rheumatic diseasesPubMed

Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker

2024Nature reviews. RheumatologyPubMed

Treat-to-target or treat-to-dissolve strategy to improve gout treatment

2024Nature geneticsPubMed

Publisher Correction: A genome-wide association analysis reveals new pathogenic pathways in gout

2024Nature geneticsPubMed

A genome-wide association analysis reveals new pathogenic pathways in gout

2026CartilagePubMed

EUROVISCO Good Medical Practice Recommendations for the Use of Viscosupplementation with Hyaluronic Acid in the Management of Knee Osteoarthritis

2026The Lancet. RheumatologyPubMed

Transcutaneous auricular vagus nerve stimulation versus sham stimulation in patients with erosive hand osteoarthritis (ESTIVAL): a randomised, multicentre, double-blind, sham-controlled trial

2025CartilagePubMed

EUROVISCO Consensus Guidelines for the Use of Hyaluronic Acid Viscosupplementation in Knee Osteoarthritis Based on Patient Characteristics

2025Osteoarthritis and cartilage openPubMed

Association between weather features and symptoms in hand osteoarthritis: Results from the DIGICOD cohort

2026The Journal of experimental medicinePubMed

ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype

2026Annals of the rheumatic diseasesPubMed

EULAR 2025 classification criteria for haemochromatosis arthropathy

2026Arthritis & rheumatology (Hoboken, N.J.)PubMed

Aryl Hydrocarbon Receptor Regulates Uric Acid Homeostasis

2025Joint bone spinePubMed

A chronic knee pain revealing an epithelioid angiosarcoma in a superficial femoral aneurysm

2026Archives of physical medicine and rehabilitationPubMed

Negative Economic Impact of Work Disability Because of Chronic Low Back Pain From the Patient Perspective: A French Cross-sectional Study of 195 Patients

2025Joint bone spinePubMed

Long-term outcomes after a functional restoration program for non-specific chronic low back pain: A 10-year longitudinal study

2025European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research SocietyPubMed

Correction: Response to functional restoration in non-specific chronic low back pain with Modic type 1 changes

2025European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

2026Rheumatology (Oxford, England)PubMed

Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis atlas

2026Rheumatology (Oxford, England)PubMed

Impact of dactylitis and enthesitis resolution on disease control in guselkumab-treated psoriatic arthritis patients with TNFi-IR: COSMOS post hoc analysis

2025Joint bone spinePubMed

Early peripheral psoriatic arthritis: Baseline features of the first 186 patients in the French Nationwide APACHE Cohort

2025Rheumatology (Oxford, England)PubMed

Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP study

2026Arthritis & rheumatology (Hoboken, N.J.)PubMed

Exploring the potential of cluster analysis in identifying disease phenotypes in CPPD: Moving from intuition to insight

2026Arthritis & rheumatology (Hoboken, N.J.)PubMed

Spermidine Reproduces the Anti-Inflammatory Effects of Intermittent Fasting and Prevents Urate and Calcium Pyrophosphate Crystal-Induced Inflammation

2026Arthritis care & researchPubMed

Exploring Patients' Profiles Associated With the Resolution of Acute Calcium Pyrophosphate Arthritis Treated With Colchicine and Prednisone: Post Hoc Analysis of a Randomized Controlled Trial

2024Arthritis & rheumatology (Hoboken, N.J.)PubMed

Features Associated With Different Inflammatory Phenotypes of Calcium Pyrophosphate Deposition Disease: A Study Using Data From the International American College of Rheumatology/EULAR Calcium Pyrophosphate Deposition Classification Criteria Cohort

2024Annals of physical and rehabilitation medicinePubMed

Arthro-distension with early and intensive mobilization for shoulder adhesive capsulitis: A randomized controlled trial

2026Rheumatology (Oxford, England)PubMed

Impact of dactylitis and enthesitis resolution on disease control in guselkumab-treated psoriatic arthritis patients with TNFi-IR: COSMOS post hoc analysis

2024Annals of physical and rehabilitation medicinePubMed

Arthro-distension with early and intensive mobilization for shoulder adhesive capsulitis: A randomized controlled trial

2026Joint bone spinePubMed

Baseline characteristics of the TRANSLATE2 cohort: A prospective study on rheumatoid arthritis-associated interstitial lung disease

2026Joint bone spinePubMed

Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update

2025Joint bone spinePubMed

IL-6: A new target in crystal-induced arthritides - A narrative review

2026JAMA internal medicinePubMed

Urate Lowering and Cardiovascular Risk-Extending the Benefits of a Treat-to-Target Strategy in Gout

2026Rheumatology (Oxford, England)PubMed

Impact of dactylitis and enthesitis resolution on disease control in guselkumab-treated psoriatic arthritis patients with TNFi-IR: COSMOS post hoc analysis

2003 · Paris 7

Effets anti-interleukine 1β in vitro des œstrogènes et de la rosiglitazone dans les chondrocytes articulaires : analyse des mécanismes d'action moléculaires

2019 · doctorant : Augustin Latourte

INFLAMMATION TISSULAIRE ET METABOLISME DU CARTILAGE : CIBLAGE DE L'INTERLEUKINE 6 AU COURS DE L'ARTHROSE.

— · doctorant : Subhalaxmi Moitra

Modulation du microbiote et perspectives métabolomiques dans l’inflammation induite par les cristaux : élucidation du rôle du jeûne intermittent et des métabolites

— · doctorant : Finja Lehnhoff

Le rôle de la TNFSF14 dans les événements cardiovasculaires liés aux crises de goutte